Showing results (11-20 of 1,076) with videos related to
Sort By:
Pageof 108
Zeitschrift Fur Kardiologie|June 21, 2016
[Therapeutic inhibition of platelets in acute coronary syndrome and in coronary intervention: mechanisms and clinical results]K Peter, T Nordt, C BodeZeitschrift Fur Kardiologie|December 1, 2000
[Therapeutic inhibition of platelets in a acute coronary syndrome and in coronary intervention: mechanisms and clinical results]K Peter, T Nordt, C BodeHerz|May 15, 2001
[GPIIb/IIIa blockers for optimizing thrombolysis in acute myocardial infarct]T K Nordt, K Peter, C BodeThrombosis Research|September 25, 2001
Intrinsic activating properties of GP IIb/IIIa blockersK Peter, M Schwarz, T Nordt, et al.Basic Research in Cardiology|May 13, 2011
Opposing effects of monomeric and pentameric C-reactive protein on endothelial progenitor cellsI Ahrens, H Domeij, S U Eisenhardt, et al.Hamostaseologie|December 7, 2007
[Helping antibodies. Targeted antithrombotic and fibrinolytic therapy]M Schwarz, C E Hagemeyer, K Peter, et al.Zeitschrift Fur Kardiologie|June 1, 1994
[Aggressive thrombolytic therapy of myocardial infarct--limits and possibilities]C Bode, K Peter, W Kübler, et al.The Journal of Clinical Endocrinology and Metabolism|April 19, 2000
Differential regulation by troglitazone of plasminogen activator inhibitor type 1 in human hepatic and vascular cellsT K Nordt, K Peter, C Bode, et al.Thrombosis and Haemostasis|March 1, 2000
Soluble vascular cell adhesion molecule-1 (VCAM-1) as potential marker of atherosclerosisK Peter, U Weirich, T K Nordt, et al.Thrombosis and Haemostasis|March 1, 2000
Plasminogen activator inhibitor type-1 (PAI-1) and its role in cardiovascular diseaseT K Nordt, K Peter, J Ruef, et al.Pageof 108